Advanced search
Publication Cover
Molecular and Cellular Biology Volume 23, 2003 - Issue 14
Submit an article Journal homepage
47
Views
134
CrossRef citations to date
0
Altmetric
Mammalian Genetic Models with Minimal or Complex Phenotypes

Mek2 Is Dispensable for Mouse Growth and Development

Louis-François Bélanger1 Centre de recherche en cancérologie de l'Université Laval, Centre Hospitalier Universitaire de Québec, Québec, Québec, CanadaG1R 2J6
,
Sophie Roy1 Centre de recherche en cancérologie de l'Université Laval, Centre Hospitalier Universitaire de Québec, Québec, Québec, CanadaG1R 2J6
,
Michel Tremblay1 Centre de recherche en cancérologie de l'Université Laval, Centre Hospitalier Universitaire de Québec, Québec, Québec, CanadaG1R 2J6
,
Barbara Brott2 Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts02138
,
Ann-Muriel Steff3 MetrioGene BioSciences, Montréal, Québec, CanadaH4P 2R2
,
Walid Mourad4 Centre de recherche du CHUL, Sainte-Foy, Québec, CanadaG1V 4G2
,
Patrice Hugo3 MetrioGene BioSciences, Montréal, Québec, CanadaH4P 2R2
,
Raymond Erikson2 Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts02138
&
Jean Charron1 Centre de recherche en cancérologie de l'Université Laval, Centre Hospitalier Universitaire de Québec, Québec, Québec, CanadaG1R 2J6Correspondence[email protected]
 show all
Pages 4778-4787 | Received 10 Feb 2003, Accepted 26 Apr 2003, Published online: 27 Mar 2023

Citations (134)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Pierluigi Scalia, Stephen J Williams, Yoko Fujita-Yamaguchi & Antonio Giordano. (2023) Cell cycle control by the insulin-like growth factor signal: at the crossroad between cell growth and mitotic regulation. Cell Cycle 22:1, pages 1-37.
Read now
Monideepa Roy, Zhigang Li & David B. Sacks. (2005) IQGAP1 Is a Scaffold for Mitogen-Activated Protein Kinase Signaling. Molecular and Cellular Biology 25:18, pages 7940-7952.
Read now
Mélanie Carpentier, Christine Guillemette, Janice L. Bailey, Guy Boileau, Lucie Jeannotte, Luc DesGroseillers & Jean Charron. (2004) Reduced Fertility in Male Mice Deficient in the Zinc Metallopeptidase NL1. Molecular and Cellular Biology 24:10, pages 4428-4437.
Read now

Articles from other publishers (131)

Hisashi Moriizumi, Yuji Kubota, Tomoyuki Tsuchiya, Ryosuke Naka & Mutsuhiro Takekawa. (2023) Caspase 3‐specific cleavage of MEK1 suppresses ERK signaling and sensitizes cells to stress‐induced apoptosis. FEBS Open Bio 13:4, pages 684-700.
Crossref
Anukriti Singh & Brian P. Hermann. (2023) Conserved Transcriptome Features Define Prepubertal Primate Spermatogonial Stem Cells as Adark Spermatogonia and Identify Unique Regulators. International Journal of Molecular Sciences 24:5, pages 4755.
Crossref
Wejdan M. AlZahrani, Shareefa A. AlGhamdi, Sayed S. Sohrab & Mohd Rehan. (2023) Investigating a Library of Flavonoids as Potential Inhibitors of a Cancer Therapeutic Target MEK2 Using in Silico Methods. International Journal of Molecular Sciences 24:5, pages 4446.
Crossref
Francesco Boato, Xiaofei GuanYanjie ZhuYoungjae Ryu, Mariel Voutounou, Christopher Rynne, Chase R. Freschlin, Paul Zumbo, Doron Betel, Katie Matho, Sergey N. MakarovZhuhao Wu, Young-Jin Son, Aapo NummenmaaJosh Z. HuangDylan J. Edwards & Jian Zhong. (2023) Activation of MAP2K signaling by genetic engineering or HF-rTMS promotes corticospinal axon sprouting and functional regeneration. Science Translational Medicine 15:677.
Crossref
Maged E. Mohamed, Nancy S. Younis, Hossam S. El-Beltagi & Omar M. Mohafez. (2022) The Synergistic Hepatoprotective Activity of Rosemary Essential Oil and Curcumin: The Role of the MEK/ERK Pathway. Molecules 27:24, pages 8910.
Crossref
Kristen Kurtzeborn, Hyuk Nam Kwon, Vladislav Iaroshenko, Imrul Faisal, Martin Ambrož, Xing Jin, Talha Qureshi, Jussi Kupari, Anneliis Ihermann-Hella, Juho Väänänen, Henna Tyynismaa, Iva Boušová, Sunghyouk Park & Satu Kuure. (2022) Comparative whole-genome transcriptome analysis in renal cell populations reveals high tissue specificity of MAPK/ERK targets in embryonic kidney. BMC Biology 20:1.
Crossref
Rahim Ullah, Qing Yin, Aidan H. Snell & Lixin Wan. (2022) RAF-MEK-ERK pathway in cancer evolution and treatment. Seminars in Cancer Biology 85, pages 123-154.
Crossref
Jung-Min Kim, Yeon-Suk Yang, Jaehyoung Hong, Sachin Chaugule, Hyonho Chun, Marjolein CH van der Meulen, Ren Xu, Matthew B Greenblatt & Jae-hyuck Shim. (2022) Biphasic regulation of osteoblast development via the ERK MAPK–mTOR pathway. eLife 11.
Crossref
Ke-Qin Gong, Carmen MikacenicMatthew E. Long, Charles W. FrevertTimothy P. Birkland, Jean Charron, Sina A. Gharib & Anne M. Manicone. (2022) MAP2K2 Delays Recovery in Murine Models of Acute Lung Injury and Associates with Acute Respiratory Distress Syndrome Outcome. American Journal of Respiratory Cell and Molecular Biology 66:5, pages 555-563.
Crossref
Katie E. Hebron, Edjay Ralph Hernandez & Marielle E. Yohe. (2022) The RASopathies: from pathogenetics to therapeutics. Disease Models & Mechanisms 15:2.
Crossref
Nicolas Houde, Laurent Beuret, Amélie Bonaud, Simon-Pierre Fortier-Beaulieu, Kim Truchon-Landry, Rifdat Aoidi, Émilie Pic, Nagham Alouche, Vincent Rondeau, Géraldine Schlecht-Louf, Karl Balabanian, Marion Espéli & Jean Charron. (2022) Fine-tuning of MEK signaling is pivotal for limiting B and T cell activation. Cell Reports 38:2, pages 110223.
Crossref
Yu-Ting Chou & Trever G. Bivona. 2022. RAS: Past, Present, and Future. RAS: Past, Present, and Future 205 236 .
A. Gulhan Ercan-Sencicek, Saravanakkumar Chennappan, Kelly Aromalaran & Maria Irene Kontaridis. 2022. Current Progress in iPSC Disease Modeling. Current Progress in iPSC Disease Modeling 65 110 .
Revathi Balasubramanian, Xuanyu Min, Peter M. J. Quinn, Quentin Lo Giudice, Chenqi Tao, Karina PolancoNeoklis MakridesJohn Peregrin, Michael Bouaziz, Yingyu MaoQian Wang, Bruna L. da Costa, Diego BuenaventuraFen Wang, Liang MaStephen H. TsangPierre J. Fabre & Xin Zhang. (2021) Phase transition specified by a binary code patterns the vertebrate eye cup. Science Advances 7:46.
Crossref
Laurent Beuret, Simon-Pierre Fortier-Beaulieu, Vincent Rondeau, Sophie Roy, Nicolas Houde, Karl Balabanian, Marion Espéli & Jean Charron. (2021) Mek1 and Mek2 Functional Redundancy in Erythropoiesis. Frontiers in Cell and Developmental Biology 9.
Crossref
Yoshiko Matsumoto Ikushima, Motoharu Awazawa, Naoki Kobayashi, Sho Osonoi, Seiichi Takemiya, Hiroshi Kobayashi, Hirotsugu Suwanai, Yuichi Morimoto, Kotaro Soeda, Jun Adachi, Masafumi Muratani, Jean Charron, Hiroki Mizukami, Noriko Takahashi & Kohjiro Ueki. (2021) MEK/ERK Signaling in β-Cells Bifunctionally Regulates β-Cell Mass and Glucose-Stimulated Insulin Secretion Response to Maintain Glucose Homeostasis. Diabetes 70:7, pages 1519-1535.
Crossref
Ming Jiang, Yinshan Fang, Yu Li, Huachao Huang, Zichen Wei, Xia Gao, Hoon-Ki Sung, Jim Hu, Li Qiang, Jian Ruan, Qixuan Chen, Dianhua Jiang, Jeffrey A. Whitsett, Xingbin Ai & Jianwen Que. (2021) VEGF receptor 2 (KDR) protects airways from mucus metaplasia through a Sox9-dependent pathway. Developmental Cell 56:11, pages 1646-1660.e5.
Crossref
Jason Schapansky, Yelena Y. Grinberg, David M. Osiecki, Emily A. Freeman, Stephen G. Walker, Eric Karran, Sujatha M. Gopalakrishnan & Robert V. Talanian. (2021) MEK1/2 activity modulates TREM2 cell surface recruitment. Journal of Biological Chemistry 296, pages 100218.
Crossref
Yu Hu, JianHua Fu, XueYan Liu & XinDong Xue. (2020) ERK1/2 Signaling Pathway Activated by EGF Promotes Proliferation, Transdifferentiation, and Migration of Cultured Primary Newborn Rat Lung Fibroblasts. BioMed Research International 2020, pages 1-9.
Crossref
Yuki Miyamoto, Marina Tanaka, Hisanaka Ito, Hiroaki Ooizumi, Katsuya Ohbuchi, Kazushige Mizoguchi, Tomohiro Torii & Junji Yamauchi. (2020) Expression of kinase-deficient MEK2 ameliorates Pelizaeus-Merzbacher disease phenotypes in mice. Biochemical and Biophysical Research Communications 531:4, pages 445-451.
Crossref
Pui-Kei Wu, Andrew Becker & Jong-In Park. (2020) Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway. International Journal of Molecular Sciences 21:15, pages 5436.
Crossref
Jing Chen, Lin Che, Chao Xu, Suzhou Zhao, Jiangfei Yang, Mengting Li, Guimei Li & Yiping Shen. (2020) Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy. Gene 733, pages 144369.
Crossref
Nadiatou Miningou & Kim T. Blackwell. (2020) The road to ERK activation: Do neurons take alternate routes?. Cellular Signalling 68, pages 109541.
Crossref
Matthias Drosten & Mariano Barbacid. (2020) Targeting the MAPK Pathway in KRAS-Driven Tumors. Cancer Cell 37:4, pages 543-550.
Crossref
Ruei‐Yue Liang, Bang‐Hung Liu, Chih‐Jou Huang, Kuan‐Ting Lin, Chih‐Chung Ko, Lin‐Lun Huang, Bin Hsu, Chun‐Ying Wu & Show‐Mei Chuang. (2019) MEK2 is a critical modulating mechanism to down‐regulate GCIP stability and function in cancer cells. The FASEB Journal 34:2, pages 1958-1969.
Crossref
Congzhen Qiao, Gresham T Richter, Weijun Pan, Yunbo Jin & Xiaoxi Lin. (2019) Extracranial arteriovenous malformations: from bedside to bench. Mutagenesis.
Crossref
Xiaomeng Xie, Xueyin Zu, Feifei Liu, Ting Wang, Xiangyu Wang, Hanyong Chen, Kangdong Liu, Penglei Wang, Fangfang Liu, Yan Zheng, Ann M. Bode, Zigang Dong & Dong Joon Kim. (2019) Purpurogallin is a novel mitogen‐activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo. Molecular Carcinogenesis.
Crossref
Jung-Min Kim, Yeon-Suk Yang, Kwang Hwan Park, Hwanhee Oh, Matthew B. Greenblatt & Jae-Hyuck Shim. (2019) The ERK MAPK Pathway Is Essential for Skeletal Development and Homeostasis. International Journal of Molecular Sciences 20:8, pages 1803.
Crossref
Kurtzeborn, Kwon & Kuure. (2019) MAPK/ERK Signaling in Regulation of Renal Differentiation. International Journal of Molecular Sciences 20:7, pages 1779.
Crossref
Harvinder Talwar, Mohamad Bouhamdan, Christian Bauerfeld, Jaya Talreja, Rifdat Aoidi, Nicolas Houde, Jean Charron & Lobelia Samavati. (2019) MEK2 Negatively Regulates Lipopolysaccharide-Mediated IL-1β Production through HIF-1α Expression. The Journal of Immunology 202:6, pages 1815-1825.
Crossref
Ze-Quan Mo, Rui Han, Jiu-Le Wang, Lu-Yun Ni, Yu-Ling Su, Xue-Li Lai, Zhi-Chang He, Hong-Ping Chen, Yan-Wei Li, Hong-Yan Sun, Xiao-Chun Luo & Xue-Ming Dan. (2019) Characterization and functional analysis of grouper (Epinephelus coioides) MEK1 and MEK2. Fish & Shellfish Immunology 84, pages 1090-1097.
Crossref
Colin J. Dinsmore & Philippe Soriano. (2018) MAPK and PI3K signaling: At the crossroads of neural crest development. Developmental Biology 444, pages S79-S97.
Crossref
Yu Hu, Jianhua Fu & Xindong Xue. (2018) Association of the proliferation of lung fibroblasts with the ERK1/2 signaling pathway in neonatal rats with hyperoxia‑induced lung fibrosis. Experimental and Therapeutic Medicine.
Crossref
Verena Pfeiffer, Rudolf Götz, Guadelupe Camarero, Helmut Heinsen, Robert Blum & Ulf Rüdiger Rapp. (2018) Impaired neuronal maturation of hippocampal neural progenitor cells in mice lacking CRAF. PLOS ONE 13:3, pages e0192067.
Crossref
Rifdat Aoidi, Nicolas Houde, Kim Landry-Truchon, Michael Holter, Kevin Jacquet, Louis Charron, Suguna Rani Krishnaswami, Benjamin D. Yu, Katherine A. Rauen, Nicolas Bisson, Jason Newbern & Jean Charron. (2018) Mek1 Y130C mice recapitulate aspects of the human Cardio-Facio-Cutaneous syndrome . Disease Models & Mechanisms.
Crossref
Siqi Zheng, Xinyuan Fan, Jie Wang, Jingyi Zhao & Peng R. Chen. (2017) Dissection of Kinase Isoforms through Orthogonal and Chemical Inducible Signaling Cascades. ChemBioChem 18:16, pages 1593-1598.
Crossref
Zhiling LuoYan ShenWei ChenXuejuan MaLiping LiuXiaoqin HuangZhaoqing YangHao Sun. (2017) Association Analysis of Nonsyndromic Congenital Heart Disease and Tag Single Nucleotide Polymorphisms of TBX20 and Genes in the Ras-MAPK Pathway . Genetic Testing and Molecular Biomarkers 21:7, pages 440-444.
Crossref
Peipei Xue, Fanfan Zeng, Qiuhong Duan, Juanjuan Xiao, Lin Liu, Ping Yuan, Linni Fan, Huimin Sun, Olesya S. Malyarenko, Hui Lu, Ruijuan Xiu, Shaoqing Liu, Chen Shao, Jianmin Zhang, Wei Yan, Zhe Wang, Jianyong Zheng & Feng Zhu. (2017) BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer. EBioMedicine 20, pages 50-60.
Crossref
Coralie Dorard, Georg Vucak & Manuela Baccarini. (2017) Deciphering the RAS/ERK pathway in vivo . Biochemical Society Transactions 45:1, pages 27-36.
Crossref
Christopher J. Halbrook, Hui-Ju Wen, Jeanine M. Ruggeri, Kenneth K. Takeuchi, Yaqing Zhang, Marina Pasca di Magliano & Howard C. Crawford. (2017) Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis. Cellular and Molecular Gastroenterology and Hepatology 3:1, pages 99-118.
Crossref
Catherine Ropert & Hugo W. Huth. 2017. Molecular Oncology: Underlying Mechanisms and Translational Advancements. Molecular Oncology: Underlying Mechanisms and Translational Advancements 67 91 .
Olivier Boucherat, Kim Landry-Truchon, Rifdat Aoidi, Nicolas Houde, Valérie Nadeau, Jean Charron & Lucie Jeannotte. (2017) Lung development requires an active ERK/MAPK pathway in the lung mesenchyme. Developmental Dynamics 246:1, pages 72-82.
Crossref
Hugo W. Huth, Jonas D. Albarnaz, Alice A. Torres, Claudio A. Bonjardim & Catherine Ropert. (2016) MEK2 controls the activation of MKK3/MKK6-p38 axis involved in the MDA-MB-231 breast cancer cell survival: Correlation with cyclin D1 expression. Cellular Signalling 28:9, pages 1283-1291.
Crossref
Dolores Diaz & Jonathan M. Maher. 2016. Drug Discovery Toxicology. Drug Discovery Toxicology 298 313 .
Lei Xing, Rylan S Larsen, George Reed Bjorklund, Xiaoyan Li, Yaohong Wu, Benjamin D Philpot, William D Snider & Jason M Newbern. (2016) Layer specific and general requirements for ERK/MAPK signaling in the developing neocortex. eLife 5.
Crossref
Rifdat AoidiAnnie MaltaisJean Charron. (2016) Functional redundancy of the kinases MEK1 and MEK2: Rescue of the Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold effect . Science Signaling 9:412.
Crossref
Christopher J. Caunt, Matthew J. Sale, Paul D. Smith & Simon J. Cook. (2015) MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road. Nature Reviews Cancer 15:10, pages 577-592.
Crossref
Mohamad Bouhamdan, Christian Bauerfeld, Jaya Talreja, Laurent Beuret, Jean Charron & Lobelia Samavati. (2015) MEK1 dependent and independent ERK activation regulates IL-10 and IL-12 production in bone marrow derived macrophages. Cellular Signalling 27:10, pages 2068-2076.
Crossref
Seung-Keun Hong, Pui-Kei Wu, Mansi Karkhanis & Jong-In Park. (2015) ERK1/2 can feedback-regulate cellular MEK1/2 levels. Cellular Signalling 27:10, pages 1939-1948.
Crossref
Sejeong Shin, Gwen R. Buel, Laura Wolgamott, David R. Plas, John M. Asara, John Blenis & Sang-Oh Yoon. (2015) ERK2 Mediates Metabolic Stress Response to Regulate Cell Fate. Molecular Cell 59:3, pages 382-398.
Crossref
David Kuhrt & Don M. Wojchowski. (2015) Emerging EPO and EPO receptor regulators and signal transducers. Blood 125:23, pages 3536-3541.
Crossref
Peter E. M. Gibbs, Tihomir Miralem & Mahin D. Maines. (2015) Biliverdin reductase: a target for cancer therapy?. Frontiers in Pharmacology 6.
Crossref
Anastasia Noël, Isabelle Poitras, Jacinthe Julien, Franck R. Petry, Françoise Morin, Jean Charron & Emmanuel Planel. (2015) ERK (MAPK) does not phosphorylate tau under physiological conditions in vivo or in vitro. Neurobiology of Aging 36:2, pages 901-902.
Crossref
Olivier Boucherat, Valérie Nadeau, Félix-Antoine Bérubé-Simard, Jean Charron & Lucie Jeannotte. (2014) Crucial requirement of ERK/MAPK signaling in respiratory tract development. Development 141:16, pages 3197-3211.
Crossref
Botond Cseh, Eszter Doma & Manuela Baccarini. (2014) “RAF” neighborhood: Protein-protein interaction in the Raf/Mek/Erk pathway. FEBS Letters 588:15, pages 2398-2406.
Crossref
Valérie Nadeau & Jean Charron. (2014) Essential role of the ERK/MAPK pathway in blood-placental barrier formation. Development 141:14, pages 2825-2837.
Crossref
Jean-Philippe Guégan, Frédéric Ezan, Luc Gailhouste, Sophie Langouët & Georges Baffet. (2014) MEK1/2 Overactivation Can Promote Growth Arrest by Mediating ERK1/2-Dependent Phosphorylation of p70S6K. Journal of Cellular Physiology 229:7, pages 903-915.
Crossref
Anneliis Ihermann-Hella, Maria Lume, Ilkka J. Miinalainen, Anniina Pirttiniemi, Yujuan Gui, Johan Peränen, Jean Charron, Mart Saarma, Frank Costantini & Satu Kuure. (2014) Mitogen-Activated Protein Kinase (MAPK) Pathway Regulates Branching by Remodeling Epithelial Cell Adhesion. PLoS Genetics 10:3, pages e1004193.
Crossref
M.J.M. Nowaczyk, B.A. Thompson, S. Zeesman, U. Moog, P.A. Sanchez-Lara, P.L. Magoulas, R.E. Falk, J.E. Hoover-Fong, D.A.S. Batista, S.M. Amudhavalli, S.M. White, G.E. Graham & K.A. Rauen. (2014) Deletion of MAP2K2/MEK2 : a novel mechanism for a RASopathy? . Clinical Genetics 85:2, pages 138-146.
Crossref
Jong-In Park. (2014) Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. Frontiers in Biology 9:2, pages 95-103.
Crossref
Ruchi Rastogi, Zhongliang Jiang, Nisar Ahmad, Rita Rosati, Yusen Liu, Laurent Beuret, Robert Monks, Jean Charron, Morris J. Birnbaum & Lobelia Samavati. (2013) Rapamycin Induces Mitogen-activated Protein (MAP) Kinase Phosphatase-1 (MKP-1) Expression through Activation of Protein Kinase B and Mitogen-activated Protein Kinase Kinase Pathways. Journal of Biological Chemistry 288:47, pages 33966-33977.
Crossref
Robert A. Whittington, Alexis Bretteville, László Virág, Charles W. Emala, Thomas O. Maurin, François Marcouiller, Carl Julien, Franck R. Petry, Noura B. El-Khoury, Françoise Morin, Jean Charron & Emmanuel Planel. (2013) Anesthesia-induced hypothermia mediates decreased ARC gene and protein expression through ERK/MAPK inactivation. Scientific Reports 3:1.
Crossref
Pawel Kocieniewski & Tomasz Lipniacki. (2013) MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response. Physical Biology 10:3, pages 035006.
Crossref
Dong Joon Kim, Mee-Hyun Lee, Kanamata Reddy, Yani Li, Do Young Lim, Hua Xie, Sung-Young Lee, Young Il Yeom, Ann M. Bode & Zigang Dong. (2013) CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo. Carcinogenesis 34:5, pages 1134-1143.
Crossref
Katarina Zmajkovicova, Veronika Jesenberger, Federica Catalanotti, Christian Baumgartner, Gloria Reyes & Manuela Baccarini. (2013) MEK1 Is Required for PTEN Membrane Recruitment, AKT Regulation, and the Maintenance of Peripheral Tolerance. Molecular Cell 50:1, pages 43-55.
Crossref
Mohamed Asrih, François Mach, Alessio Nencioni, Franco Dallegri, Alessandra Quercioli & Fabrizio Montecucco. (2013) Role of Mitogen-Activated Protein Kinase Pathways in Multifactorial Adverse Cardiac Remodeling Associated with Metabolic Syndrome. Mediators of Inflammation 2013, pages 1-11.
Crossref
Jean-Philippe Guégan, Frédéric Ezan, Nathalie Théret, Sophie Langouët & Georges Baffet. (2013) MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells. Carcinogenesis 34:1, pages 38-47.
Crossref
J. L. Bromberg-White, N. J. Andersen & N. S. Duesbery. (2012) MEK genomics in development and disease. Briefings in Functional Genomics 11:4, pages 300-310.
Crossref
Jean Charron, Vickram Bissonauth & Valérie Nadeau. (2012) Implication of MEK1 and MEK2 in the establishment of the blood–placenta barrier during placentogenesis in mouse. Reproductive BioMedicine Online 25:1, pages 58-67.
Crossref
Valérie Nadeau, Vickram Bissonauth & Jean Charron. (2012) Le rôle des kinases Mek1 et Mek2 dans la formation de la barrière hématoplacentaire chez la souris . médecine/sciences 28:4, pages 409-415.
Crossref
Damien Carignan, Olivier Désy & Pedro O. de Campos-Lima. (2012) The Dysregulation of the Monocyte/Macrophage Effector Function Induced by Isopropanol Is Mediated by the Defective Activation of Distinct Members of the AP-1 Family of Transcription Factors. Toxicological Sciences 125:1, pages 144-156.
Crossref
Jingcai Wang, Liang Chen, Chia-I Ko, Lin Zhang, Alvaro Puga & Ying Xia. (2012) Distinct Signaling Properties of Mitogen-activated Protein Kinase Kinases 4 (MKK4) and 7 (MKK7) in Embryonic Stem Cell (ESC) Differentiation. Journal of Biological Chemistry 287:4, pages 2787-2797.
Crossref
Bo Wang, Hao Zhang, Meng Zhu, Zhijun Luo & Yihong Peng. (2012) MEK1–ERKs signal cascade is required for the replication of Enterovirus 71 (EV71). Antiviral Research 93:1, pages 110-117.
Crossref
Soichi YamashitaPing TaiJean CharronCheMyong Ko & Mario Ascoli. (2011) The Leydig Cell MEK/ERK Pathway Is Critical for Maintaining a Functional Population of Adult Leydig Cells and for Fertility. Molecular Endocrinology 25:7, pages 1211-1222.
Crossref
Rafael B. Blasco, Sarah Francoz, David Santamaría, Marta Cañamero, Pierre Dubus, Jean Charron, Manuela Baccarini & Mariano Barbacid. (2011) c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung Carcinoma. Cancer Cell 19:5, pages 652-663.
Crossref
Eva Chung & Motonari Kondo. (2010) Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development. Immunologic Research 49:1-3, pages 248-268.
Crossref
Okkyung Rho, Dae Joon Kim, Karou Kiguchi & John DiGiovanni. (2011) Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Molecular Carcinogenesis 50:4, pages 264-279.
Crossref
Chih-Shia Lee, Karl J. Dykema, Danielle M. Hawkins, David M. Cherba, Craig P. Webb, Kyle A. Furge & Nicholas S. Duesbery. (2011) MEK2 Is Sufficient but Not Necessary for Proliferation and Anchorage-Independent Growth of SK-MEL-28 Melanoma Cells. PLoS ONE 6:2, pages e17165.
Crossref
Jason M. Newbern, Xiaoyan Li, Sarah E. Shoemaker, Jiang Zhou, Jian Zhong, Yaohong Wu, Daniel Bonder, Steven Hollenback, Giovanni Coppola, Daniel H. Geschwind, Gary E. Landreth & William D. Snider. (2011) Specific Functions for ERK/MAPK Signaling during PNS Development. Neuron 69:1, pages 91-105.
Crossref
Colin D. Weekes & Manuel Hidalgo. 2011. Principles of Anticancer Drug Development. Principles of Anticancer Drug Development 403 461 .
Robert E. BolcomeIIIIII & Joanne Chan. (2010) Constitutive MEK1 Activation Rescues Anthrax Lethal Toxin-Induced Vascular Effects In Vivo . Infection and Immunity 78:12, pages 5043-5053.
Crossref
Marco Tartaglia & Bruce D. Gelb. (2010) Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Annals of the New York Academy of Sciences 1214:1, pages 99-121.
Crossref
Reiner Wimmer & Manuela Baccarini. (2010) Partner exchange: protein–protein interactions in the Raf pathway. Trends in Biochemical Sciences 35:12, pages 660-668.
Crossref
Karim J Brandt, Rakel Carpintero, Lyssia Gruaz, Nicolas Molnarfi & Danielle Burger. (2010) A novel MEK2/PI3Kδ pathway controls the expression of IL-1 receptor antagonist in IFN-β-activated human monocytes. Journal of Leukocyte Biology 88:6, pages 1191-1200.
Crossref
Hao Zhang, Hai Feng, Lingqi Luo, Qi Zhou, Zhijun Luo & Yihong Peng. (2010) Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2. Virus Research 150:1-2, pages 22-27.
Crossref
Matthias Drosten, Alma Dhawahir, Eleanor Y M Sum, Jelena Urosevic, Carmen G Lechuga, Luis M Esteban, Esther Castellano, Carmen Guerra, Eugenio Santos & Mariano Barbacid. (2010) Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. The EMBO Journal 29:6, pages 1091-1104.
Crossref
Peng-Yuan WangJaladanki N. RaoTongtong ZouLan LiuLan XiaoTing-Xi YuDouglas J. TurnerMyriam GorospeJian-Ying Wang. (2010) Post-transcriptional regulation of MEK-1 by polyamines through the RNA-binding protein HuR modulating intestinal epithelial apoptosis. Biochemical Journal 426:3, pages 293-306.
Crossref
Izhak Kehat & Jeffery D. Molkentin. (2010) Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy. Annals of the New York Academy of Sciences 1188:1, pages 96-102.
Crossref
Norman J. Kennedy & Roger J. Davis. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling 1315 1328 .
Wenhu HuangAmy H. YangDiane MatsumotoWalter ColletteLisa MarroquinMira KoShirley AguirreHusam S. Younis. (2009) PD0325901, a Mitogen-Activated Protein Kinase Kinase Inhibitor, Produces Ocular Toxicity in a Rabbit Animal Model of Retinal Vein Occlusion. Journal of Ocular Pharmacology and Therapeutics 25:6, pages 519-530.
Crossref
Puji Astuti, Tanya Pike, Charlotte Widberg, Elizabeth Payne, Angus Harding, John Hancock & Brian Gabrielli. (2009) MAPK Pathway Activation Delays G2/M Progression by Destabilizing Cdc25B. Journal of Biological Chemistry 284:49, pages 33781-33788.
Crossref
Pearl P.Y. Lie, C. Yan Cheng & Dolores D. Mruk. (2009) Coordinating cellular events during spermatogenesis: a biochemical model. Trends in Biochemical Sciences 34:7, pages 366-373.
Crossref
Florence A. Scholl, Phillip A. Dumesic, Deborah I. Barragan, Kazutoshi Harada, Jean Charron & Paul A. Khavari. (2009) Selective Role for Mek1 but not Mek2 in the Induction of Epidermal Neoplasia. Cancer Research 69:9, pages 3772-3778.
Crossref
Valérie NadeauStéphanie GuillemetteLouis-François BélangerOlivier JacobSophie RoyJean Charron. (2009) Map2k1 and Map2k2 genes contribute to the normal development of syncytiotrophoblasts during placentation . Development 136:8, pages 1363-1374.
Crossref
F A Scholl, P A Dumesic, D I Barragan, J Charron & P A Khavari. (2009) Mek1/2 gene dosage determines tissue response to oncogenic Ras signaling in the skin. Oncogene 28:12, pages 1485-1495.
Crossref
Federica Catalanotti, Gloria Reyes, Veronika Jesenberger, Gergana Galabova-Kovacs, Ricardo de Matos Simoes, Oliviero Carugo & Manuela Baccarini. (2009) A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal. Nature Structural & Molecular Biology 16:3, pages 294-303.
Crossref
Marcel Schilling, Thomas Maiwald, Stefan Hengl, Dominic Winter, Clemens Kreutz, Walter Kolch, Wolf D Lehmann, Jens Timmer & Ursula Klingmüller. (2009) Theoretical and experimental analysis links isoform‐ specific ERK signalling to cell fate decisions. Molecular Systems Biology 5:1.
Crossref
Luc Gailhouste, Frédéric Ezan, Anne Bessard, Christophe Frémin, Julie Rageul, Sophie Langouët & Georges Baffet. (2009) RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo . International Journal of Cancer, pages NA-NA.
Crossref
Thomas A Hawkins, Florencia Cavodeassi, Ferenc Erdélyi, Gábor Szabó & Zsolt Lele. (2008) The small molecule Mek1/2 inhibitor U0126 disrupts the chordamesoderm to notochord transition in zebrafish. BMC Developmental Biology 8:1.
Crossref
William E. Tidyman & Katherine A. Rauen. (2008) Noonan, Costello and cardio–facio–cutaneous syndromes: dysregulation of the Ras–MAPK pathway. Expert Reviews in Molecular Medicine 10.
Crossref
Jürgen Klammt, Roland Pfäffle, Haim Werner & Wieland Kiess. (2008) IGF signaling defects as causes of growth failure and IUGR. Trends in Endocrinology & Metabolism 19:6, pages 197-205.
Crossref
Jessica Shama, Raquel Garcia-Medina, Jacques Pouysségur & Emmanuel Vial. (2008) Major contribution of MEK1 to the activation of ERK1/ERK2 and to the growth of LS174T colon carcinoma cells. Biochemical and Biophysical Research Communications 372:4, pages 845-849.
Crossref
Yoko Aoki, Tetsuya Niihori, Yoko Narumi, Shigeo Kure & Yoichi Matsubara. (2008) The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Human Mutation 29:8, pages 992-1006.
Crossref
Judith S. Sebolt-Leopold. (2008) Advances in the Development of Cancer Therapeutics Directed against the RAS-Mitogen-Activated Protein Kinase Pathway. Clinical Cancer Research 14:12, pages 3651-3656.
Crossref
Thomas W. Sturgill. (2008) MAP kinase: It’s been longer than fifteen minutes. Biochemical and Biophysical Research Communications 371:1, pages 1-4.
Crossref
Tal Almog, Shlomi Lazar, Nachum Reiss, Nir Etkovitz, Eyal Milch, Nir Rahamim, Masha Dobkin-Bekman, Ronit Rotem, Moshe Kalina, Jacob Ramon, Arieh Raziel, Haim Brietbart, Rony Seger & Zvi Naor. (2008) Identification of Extracellular Signal-regulated Kinase 1/2 and p38 MAPK as Regulators of Human Sperm Motility and Acrosome Reaction and as Predictors of Poor Spermatozoan Quality. Journal of Biological Chemistry 283:21, pages 14479-14489.
Crossref
Ellen Skarpen, Liv Ingrid Flinder, Carola Maria Rosseland, Sigurd Ørstavik, Lene Wierød, Morten Pedersen Oksvold, Bjørn Steen Skålhegg & Henrik Sverre Huitfeldt. (2007) MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments. The FASEB Journal 22:2, pages 466-476.
Crossref
Elke Burgermeister & Rony Seger. (2008) PPAR and MEK Interactions in Cancer . PPAR Research 2008, pages 1-16.
Crossref
Pablo Rodriguez‐Viciana & Katherine A. Rauen. 2008. Small GTPases in Disease, Part A. Small GTPases in Disease, Part A 277 289 .
Yoav D. Shaul & Rony Seger. (2007) The MEK/ERK cascade: From signaling specificity to diverse functions. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1773:8, pages 1213-1226.
Crossref
Nancy Gerits, Sergiy Kostenko & Ugo Moens. (2007) In vivo functions of mitogen-activated protein kinases: conclusions from knock-in and knock-out mice. Transgenic Research 16:3, pages 281-314.
Crossref
Jian Zhong, Xiaoyan Li, Cara McNamee, Adele P Chen, Manuela Baccarini & William D Snider. (2007) Raf kinase signaling functions in sensory neuron differentiation and axon growth in vivo. Nature Neuroscience 10:5, pages 598-607.
Crossref
Florence A. Scholl, Phillip A. Dumesic, Deborah I. Barragan, Kazutoshi Harada, Vickram Bissonauth, Jean Charron & Paul A. Khavari. (2007) Mek1/2 MAPK Kinases Are Essential for Mammalian Development, Homeostasis, and Raf-Induced Hyperplasia. Developmental Cell 12:4, pages 615-629.
Crossref
Sébastien Tabariès, Margot Lemieux, Josée Aubin & Lucie Jeannotte. (2007) Comparative analysis ofHoxa5 allelic series. genesis 45:4, pages 218-228.
Crossref
P E Depeille, Y Ding, J L Bromberg-White & N S Duesbery. (2007) MKK signaling and vascularization. Oncogene 26:9, pages 1290-1296.
Crossref
Colin D. Weekes & Manuel Hidalgo. 2007. Cancer Immunotherapy. Cancer Immunotherapy 117 148 .
Vickram BissonauthSophie RoyMathieu GravelStéphanie GuillemetteJean Charron. (2006) Requirement for Map2k1 ( Mek1 ) in extra-embryonic ectoderm during placentogenesis . Development 133:17, pages 3429-3440.
Crossref
Satoko Nishimoto & Eisuke Nishida. (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO reports 7:8, pages 782-786.
Crossref
Sarah M. Battcock, Thaddeus W. Collier, Dong Zu & Kensuke Hirasawa. (2006) Negative Regulation of the Alpha Interferon-Induced Antiviral Response by the Ras/Raf/MEK Pathway. Journal of Virology 80:9, pages 4422-4430.
Crossref
Pablo Rodriguez-VicianaOsamu TetsuWilliam E. TidymanAnne L. EstepBrenda A. CongerMolly Santa CruzFrank McCormickKatherine A. Rauen. (2006) Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome. Science 311:5765, pages 1287-1290.
Crossref
Daniela Corda, Antonino Colanzi & Alberto Luini. (2006) The multiple activities of CtBP/BARS proteins: the Golgi view. Trends in Cell Biology 16:3, pages 167-173.
Crossref
Chiara Vantaggiato, Ivan Formentini, Attilio Bondanza, Chiara Bonini, Luigi Naldini & Riccardo Brambilla. (2006) ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. Journal of Biology 5:5, pages 14.
Crossref
Eli M. Wallace, Tammie C. Yeh, Ellen R. Laird, James F. Blake & Joseph Lyssikatos. 2007. Cancer. Cancer 83 132 .
Florence A. Scholl, Phillip A. Dumesic & Paul A. Khavari. (2005) Effects of active MEK1 expression in vivo. Cancer Letters 230:1, pages 1-5.
Crossref
Ching-Hang Wong & C. Yan Cheng. (2005) Mitogen-activated protein kinases, adherens junction dynamics, and spermatogenesis: A review of recent data. Developmental Biology 286:1, pages 1-15.
Crossref
Siegfried Ussar & Tilman Voss. (2004) MEK1 and MEK2, Different Regulators of the G1/S Transition. Journal of Biological Chemistry 279:42, pages 43861-43869.
Crossref
Florence A. Scholl, Phillip A. Dumesic & Paul A. Khavari. (2004) Mek1 Alters Epidermal Growth and Differentiation. Cancer Research 64:17, pages 6035-6040.
Crossref
Amy Inselman & Mary Ann Handel. (2004) Mitogen-Activated Protein Kinase Dynamics During the Meiotic G2/MI Transition of Mouse Spermatocytes1. Biology of Reproduction 71:2, pages 570-578.
Crossref
Teiji Wada & Josef M Penninger. (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23:16, pages 2838-2849.
Crossref
Xiaoqi Liu, Shi Yan, Tianhua Zhou, Yasuhiko Terada & Raymond L Erikson. (2004) The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23:3, pages 763-776.
Crossref
Y. Miyamoto, P. Reddig & R. L. Juliano. 2004. Cell Adhesion. Cell Adhesion 197 216 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.